IRB.NS(IRB.NS)
IRB.NS
No analyst ratings available
No analyst price targets available for IRB.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $82.22B | $90.08B | $86.22B |
| Low | $61.41B | $64.68B | $70.06B |
| High | $96.70B | $110.81B | $101.56B |
| EBITDA Avg | $47.03B | $52.51B | $53.04B |
| Low | $41.93B | $47.48B | $48.13B |
| High | $48.94B | $53.89B | $58.29B |
| EBIT Avg | $36.36B | $42.29B | $43.25B |
| Low | $31.26B | $37.26B | $38.34B |
| High | $38.27B | $43.67B | $48.50B |
| Net Income Avg | $13.15B | $17.41B | $18.10B |
| Low | $9.49B | $13.80B | $14.58B |
| High | $14.53B | $18.40B | $21.87B |
| EPS Avg | $1.04 | $1.34 | $1.50 |
| Low | $0.78 | $1.14 | $1.20 |
| High | $1.20 | $1.51 | $1.80 |
| Analysts (Rev / EPS) | 5 / 4 | 5 / 4 | 3 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $19.30B | $21.69B | $23.96B |
| Low | $19.30B | $21.69B | $23.96B |
| High | $19.30B | $21.69B | $23.96B |
| EBITDA Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| EBIT Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| Net Income Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| EPS Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| Analysts (Rev / EPS) | 1 / — | 1 / — | 1 / — |